Sfoglia per Autore
US features of liver surface nodularity as a predictor of severe fibrosis in chronic hepatitis C
2005 M. Viganò, S. Visentin, A. Aghemo, M. G. Rumi, G. Ronchi, A. Colli, A. Colucci, S. Paggi, M. Fraquelli, D. Conte
Low rates of sustained virological response to interferon and ribavirin therapy in genotype 3 infected patients with compensated cirrhosis
2005 A. Aghemo, M. Rumi, R. D’Ambrosio, R. Soffredini, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies
2005 V. Monti, A. Aghemo, M.G. Rumi, M.F. Donato, E. Del Ninno, M. Colombo
Increased survival of patients with HCV-related cirrhosis with a long-term response to interferon therapy
2005 M. Viganò, A. Aghemo, M. Iavarone, P. Lampertico, M. Rumi, A. Sangiovanni, E. Del Ninno, M. Colombo
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
2006 M. Rumi, R. D'Ambrosio, A.M. Aghemo
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3α hepatitis C virus infection
2006 A. Aghemo, M.G. Rumi, R. Soffredini, R. D'Ambrosio, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection.
2007 G. Taliani, P. Rucci, E. Biliotti, L. Cirrincione, A. Aghemo,A. Alberti,PL. Almasio,D. Bartolozzi,N. Caporaso,R. Coppola,M. Chiaramonte,A. Floreani,GB Gaeta,M. Persico,G. Secchi,I. Versace, S. Zacharia,A. Mele
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis
2007 M. Viganò, A. Aghemo, M. Iavarone
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients : a single-centre study
2007 M.G. Rumi, A.M. Aghemo, R. D'Ambrosio, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
New kids on the blocks for anti-HCV therapy
2007 A. Aghemo, M. Colombo
Optimizing treatment with pegylated interferon-ribavirin of genotype 3 chronic hepatitis C : more questions than answers
2008 A. Aghemo, R. D’Ambrosio, M.G. Rumi, M. Colombo
The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy
2008 R. D’Ambrosio, A. Aghemo, M.G. Rumi, M. Primignani, A. Dell’Era, R. De Franchis, S. De Nicola, P. Lampertico, M. Colombo
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients
2008 A. Aghemo, M. Rumi, G.M. Prati, S. Monico, M.F. Donato, M. Colombo
Liver cell proliferation and liver cancer risk in patients with hepatitis C virus-related cirrhosis under antiviral treatment
2008 E. Arosio, M.F. Donato, M.G. Rumi, A. Aghemo, A. Sangiovanni, M. Balestrieri, G. Ronchi, M. Colombo
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008 A. Aghemo, L. Ronzoni, M. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Recovery after L-DOPA treatment in peg-interferon and ribavirin induced parkinsonism
2008 A. Bersano, A. Aghemo, M. Rumi, E. Ballabio, L. Candelise, M. Colombo
Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern
2008 M. Iavarone, A. Sangiovanni, G. Ronchi, L.V. Forzenigo, A. Aghemo, P. Lampertico, M. Colombo
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis
2008 T. Stroffolini, P.L. Almasio, M. Persico, S. Bollani, L. Benvegnù, G. Di Costanzo, G. Pastore, A. Aghemo, G. Stornaiuolo, A. Mangia, P. Andreone, M. Stanzione, G. Mazzella, G. Saracco, P. Del Poggio, S. Bruno, I. Association of the Study of the Liver Disease
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
2008 A. Aghemo, M.G. Rumi, M. Colombo
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients
2008 A. Aghemo, M. Rumi, S. Monico, G.M. Prati, G. Ronchi, M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile